Literature DB >> 21494028

Impetigo herpetiformis with gestational hypertension: a case report and literature review.

Y H Huang1, Y P Chen, C C Liang, Y L Chang, C C Hsieh.   

Abstract

BACKGROUND: Impetigo herpetiformis (IH) is a rare skin disorder that occurs during pregnancy. It was previously associated with high maternal and fetal mortality and morbidity, but now has a better prognosis. CASE REPORT: We report a case of a pregnant woman with IH who presented with generalized erythematous pustular eruptions in the 32nd week of gestation. The IH progressed rapidly, and gestational hypertension was observed in the 36th week. The lesions did not subside, despite treatment with corticosteroids and phototherapy. She delivered a healthy male baby via cesarean section in the 37th week. One month after her delivery, her skin returned to normal, except for residual pigmentation, with complete recovery 3 months postpartum.
CONCLUSION: An experienced medical team comprising obstetricians, dermatologists, perinatologists and neonatologists is critical to aggressively treat this life-threatening specific dermatosis of pregnancy and to prevent ensuing complications, such as fluid and electrolyte imbalance, secondary infection and placental insufficiency.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21494028     DOI: 10.1159/000326913

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  6 in total

1.  Combination treatment of captopril and prazosin to treat patients with gestational hypertension.

Authors:  Bo Hong; Xiang Ding; Hongmei Iia; Jianmei Zhang
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

2.  Successful Treatment of Recurrent Pustular Psoriasis of Pregnancy with Secukinumab: A Case Report.

Authors:  Na Liu; Lin Zhu; Yuanyuan Cheng; Ning Yu; Xuemei Yi; Yangfeng Ding
Journal:  Acta Derm Venereol       Date:  2020-08-19       Impact factor: 3.875

Review 3.  Pustular psoriasis of pregnancy: current perspectives.

Authors:  Megha K Trivedi; Alexandra R Vaughn; Jenny E Murase
Journal:  Int J Womens Health       Date:  2018-02-26

Review 4.  Impetigo Herpetiformis: Review of Pathogenesis, Complication, and Treatment.

Authors:  Nastaran Namazi; Sahar Dadkhahfar
Journal:  Dermatol Res Pract       Date:  2018-04-04

5.  Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway.

Authors:  Xudong Zhao; Xietong Wang
Journal:  Mol Med Rep       Date:  2018-05-23       Impact factor: 2.952

6.  Recurrent impetigo herpetiformis: case report.

Authors:  Emmanuel Wekesa Wamalwa
Journal:  Pan Afr Med J       Date:  2017-07-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.